SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-022031
Filing Date
2024-04-25
Accepted
2024-04-25 16:05:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20021689x2_defa14a.htm DEFA14A 9042
2 ny20021689x2_na01.jpg GRAPHIC 1228308
3 ny20021689x2_na02.jpg GRAPHIC 1047706
  Complete submission text file 0001140361-24-022031.txt   3142305
Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38959 | Film No.: 24876171
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)